Previous studies have shown that functional Au DENPs can transport siPDL1 (programmed siRNA-PD-L1) to cancer cells, effectively down-regulate the expression of PD-L1 protein, and increase the infiltration of CD8+ and CD4+ T cells in tumor tissues and spleen, thereby promoting immunotherapy. The gene discussed is CD8A; the disease is neoplasm.